Phase 2 Stroke Trial, Recruiting NCT07415655 Sponsor: University Hospital Hradec Kralove Condition: Stroke
Back to Stroke

Phase 2 Stroke Trial, Recruiting

NCT07415655
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had an ischemic stroke (a stroke caused by a blocked blood vessel) in the front part of the brain, whether or not they received clot-dissolving medication
  • People whose doctors have determined that a procedure to open or treat a blocked blood vessel in the brain is needed

Who may not be able to join:

  • People who are pregnant or breastfeeding
  • People who have a known allergy or bad reaction to albumin (a protein found in blood)
  • People who have too much fluid in their body (confirm with trial site)
  • People who have too much sodium in their blood
  • People who are already taking part in another clinical trial or research study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +420495833218

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
University Hospital Hradec Kralove
Registry
ClinicalTrials.gov
Start date
3 February 2026
Est. completion
1 February 2027

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Syndecan-1 serum concentration; Glycoyaminoglycans in the urine concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov